142 related articles for article (PubMed ID: 1806789)
1. [Evaluation of the results of chemotherapy in squamous cell bronchial carcinoma].
Nagorni-Obradović L
Med Pregl; 1991; 44(9-10):387-90. PubMed ID: 1806789
[TBL] [Abstract][Full Text] [Related]
2. [Antineoplastic chemotherapy for bronchial carcinoma].
Tanneberger S
Arch Geschwulstforsch; 1985; 55(1):63-71. PubMed ID: 2985017
[TBL] [Abstract][Full Text] [Related]
3. Chemotherapy for bronchogenic carcinoma. Methotrexate, doxorubicin, cyclophosphamide, and lomustine.
Chahinian PA; Arnold DJ; Cohen JM; Purpora DP; Jaffrey IS; Teirstein AS; Kirschner PA; Holland JF
JAMA; 1977 May; 237(22):2392-6. PubMed ID: 576939
[TBL] [Abstract][Full Text] [Related]
4. Combination chemotherapy in metastatic or recurrent non-small cell bronchogenic carcinoma. 5-year results.
Ojala A; Nikkanen VN; Paloheimo S; Palojoki A; Thölix E
Strahlentherapie; 1983 Dec; 159(12):775-7. PubMed ID: 6364459
[TBL] [Abstract][Full Text] [Related]
5. [MACC plus thymostimulin (TP-1 Serono) therapy of small cell bronchogenic carcinoma. Clinico-immunologic evaluation of the results of a randomized trial].
Salvati F; Pallotta G; Antilli A; Nunziati F; De Marinis F; Lucchesi M
G Ital Chemioter; 1984; 31(1-2):185-9. PubMed ID: 6088341
[No Abstract] [Full Text] [Related]
6. Adjuvant chemotherapy for invasive urothelial cancer: experience with a methotrexate, vincristine, cisplatin, cyclophosphamide, adriamycin and bleomycin (MVP-CAB) regimen: a preliminary report.
Gohji K; Higuchi A; Maruyama S; Minayoshi K; Fujii A; Itoh N; Hasunuma Y; Tanaka H; Izumi T
Jpn J Clin Oncol; 1993 Oct; 23(5):291-8. PubMed ID: 7693990
[TBL] [Abstract][Full Text] [Related]
7. [Value of polychemotherapy for bronchogenic carcinoma other than undifferentiated small cell carcinoma].
Laberge F; Desmeules M; Bergeron D; La Forge J; Cormier Y
Union Med Can; 1984 Mar; 113(3):222-4. PubMed ID: 6730096
[No Abstract] [Full Text] [Related]
8. [Polychemotherapy using methotrexate, adriamycin, cyclophosphamide and CCNU (MACC) in patients with advanced adenocarcinoma and large cell carcinoma of the lung].
Karnicka-Młodkowska H; Jassem J; Mierzewski P; Słupek A; Mierzwa W; Decker E; Prokop A; Krawczyk K; Kowal E; Firlik M
Pneumonol Pol; 1986 Dec; 54(12):546-51. PubMed ID: 3035511
[No Abstract] [Full Text] [Related]
9. Combined-modality treatment of inoperable lung cancer (i.v. immunotherapy, chemotherapy, and radiotherapy).
Robinson E; Haim N; Segal R; Veseley Z; Mekori T
Cancer Treat Rep; 1985 Mar; 69(3):251-8. PubMed ID: 2983892
[TBL] [Abstract][Full Text] [Related]
10. Cyclophosphamide, doxorubicin, and cisplatin in the treatment of non-small cell bronchogenic carcinoma.
Evans WK; Feld R; DeBoer G; Osoba D; Curtis JE; Baker MA; Myers RE; Quirt IC; Pritchard KI; Brown TC; Kutas GJ; Blackstein ME; Ottema B; Millband L
Cancer Treat Rep; 1981; 65(11-12):947-54. PubMed ID: 7028256
[TBL] [Abstract][Full Text] [Related]
11. Combination chemotherapy in inoperable lung cancer--a trial of 2 regimens.
Behera D; Malik SK
Indian J Chest Dis Allied Sci; 1989; 31(1):21-4. PubMed ID: 2509339
[TBL] [Abstract][Full Text] [Related]
12. MACC (methotrexate, doxorubicin, cyclophosphamide and lomustine) versus cis-platinum and etoposide in the treatment of advanced non-small cell lung cancer.
Buccheri G; Ferrigno D; Curcio A; Vola F; Mattalia E
Chemioterapia; 1986 Feb; 5(1):53-7. PubMed ID: 3955784
[TBL] [Abstract][Full Text] [Related]
13. [Combination chemotherapy for bronchogenic carcinoma based on cell type].
Ohta M; Hara N; Ichikawa Y; Kanda T; Shima K; Hokama M
Gan To Kagaku Ryoho; 1986 Jan; 13(1):86-94. PubMed ID: 2417564
[TBL] [Abstract][Full Text] [Related]
14. Cisplatin, doxorubicin, cyclophosphamide, lomustine, and vincristine (PACCO) in the treatment of non-small cell bronchogenic carcinoma.
Whitehead RP; Rosenbaum PR; Carbone PP
Cancer Treat Rep; 1984 May; 68(5):771-3. PubMed ID: 6539171
[TBL] [Abstract][Full Text] [Related]
15. [Results of a sequential polychemotherapy (adriamycin, vincristine, cyclophosphamide, methotrexate) in small-cell and undifferentiated bronchial cancer].
Taytard A; Chomy P; Courty G; Gachie JP; Roquain J
Rev Fr Mal Respir; 1980; 8(3):225-32. PubMed ID: 6314444
[TBL] [Abstract][Full Text] [Related]
16. Methotrexate in the chemotherapy of lung cancer.
Smyth JF; Ford HT
Cancer Treat Rep; 1981; 65 Suppl 1():161-3. PubMed ID: 6275986
[TBL] [Abstract][Full Text] [Related]
17. Chemotherapy versus chemoimmunotherapy with levamisole or Corynebacterium parvum in advanced lung cancer.
Chahinian AP; Goldberg J; Holland JF; Reisman A; Jaffrey IS; Mandel EM
Cancer Treat Rep; 1982 Jun; 66(6):1291-7. PubMed ID: 6282455
[TBL] [Abstract][Full Text] [Related]
18. [Polychemotherapy in inoperable bronchial carcinoma].
Schmidt CG
Strahlentherapie; 1984 Feb; 160(2):71-6. PubMed ID: 6328699
[TBL] [Abstract][Full Text] [Related]
19. Combined chemotherapy (vindesine, lomustine, cisplatin, and cyclophosphamide) and radical radiotherapy in inoperable nonmetastatic squamous cell carcinoma of the lung.
Le Chevalier T; Arriagada R; Baldeyrou P; Martin M; Duroux P; Jacquotte A; Sancho-Garnier H; Rouesse J
Cancer Treat Rep; 1985 May; 69(5):469-72. PubMed ID: 4039979
[TBL] [Abstract][Full Text] [Related]
20. Combination chemotherapy in squamous cell carcinoma of the lung.
Krzakowski MJ; Swierz J
Chemioterapia; 1984 Apr; 3(2):75-8. PubMed ID: 6085285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]